Literature DB >> 21889715

Estrogen carcinogenesis in breast cancer.

Doris Germain1.   

Abstract

Many studies have reported a correlation between elevated estrogen blood levels and breast cancer and this observation has raised controversy concerning the long-term use of hormonal replacement therapy. This review will not address further this controversial topic; but rather, this review focuses on the role of estrogen signaling in first, the normal development of the breast and second, how alterations of this signaling pathway contribute to breast cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889715     DOI: 10.1016/j.ecl.2011.05.009

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  26 in total

Review 1.  Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.

Authors:  Jiri Polivka; Irem Altun; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-02-08       Impact factor: 6.543

2.  Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.

Authors:  Yohan Oh; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

3.  C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.

Authors:  Mutsuko Yamamoto-Ibusuki; Yutaka Yamamoto; Saori Fujiwara; Aiko Sueta; Satoko Yamamoto; Mitsuhiro Hayashi; Mai Tomiguchi; Takashi Takeshita; Hirotaka Iwase
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

4.  Job Authority and Breast Cancer.

Authors:  Tetyana Pudrovska
Journal:  Soc Forces       Date:  2013

5.  A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressing HER2 expression in breast cancer.

Authors:  Panhong Zhang; Yutao Yang; Kai Qian; Lianlian Li; Cuiping Zhang; Xiaoyi Fu; Xiumei Zhang; Huan Chen; Qiongqing Liu; Shengnan Cao; Jiajun Cui
Journal:  J Biol Chem       Date:  2020-07-20       Impact factor: 5.157

6.  Variants of estrogen-related genes and breast cancer risk in European and African American women.

Authors:  Lei Quan; Chi-Chen Hong; Gary Zirpoli; Michelle R Roberts; Thaer Khoury; Lara E Sucheston-Campbell; Dana H Bovbjerg; Lina Jandorf; Karen Pawlish; Gregory Ciupak; Warren Davis; Elisa V Bandera; Christine B Ambrosone; Song Yao
Journal:  Endocr Relat Cancer       Date:  2014-09-16       Impact factor: 5.678

7.  Overexpression of estrogen receptor beta alleviates the toxic effects of beta-amyloid protein on PC12 cells via non-hormonal ligands.

Authors:  Hui Wang; Lihui Si; Xiaoxi Li; Weiguo Deng; Haimiao Yang; Yuyan Yang; Yan Fu
Journal:  Neural Regen Res       Date:  2012-05-15       Impact factor: 5.135

8.  Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer.

Authors:  Karin Zins; Maurice Mogg; Christian Schneeberger; Dietmar Abraham; Martin Schreiber
Journal:  Int J Mol Sci       Date:  2014-01-07       Impact factor: 5.923

9.  Influence of CYP19A1 gene expression levels in women with breast cancer: a systematic review of the literature.

Authors:  Maria da Conceição Barros-Oliveira; Danylo Rafhael Costa-Silva; Alesse Ribeiro Dos Santos; Renato Oliveira Pereira; José Maria Soares-Júnior; Benedito Borges da Silva
Journal:  Clinics (Sao Paulo)       Date:  2021-06-14       Impact factor: 2.365

10.  Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.

Authors:  Begoña Pineda; Miguel Ángel García-Pérez; Antonio Cano; Ana Lluch; Pilar Eroles
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.